Anti-biofilm activity of silver nanoparticles against different microorganisms

Biofouling

Volumn 29, Issue 6, 2013, Pages 651-660

  Martinez Gutierrez, Fidel ^a   Boegli, Laura ^b   Agostinho, Alessandra ^b   Sánchez, Elpidio Morales ^a   Bach, Horacio ^c   Ruiz, Facundo ^a   James, Garth ^b  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b MONTANA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

anti biofilm activity; biofilm; CDC reactor; polycarbonate membrane; Pseudomonas aeruginosa; silver nanoparticles

Indexed keywords

METAL NANOPARTICLE; POLYCARBONATE; POLYMER; SILVER;

ANTIFOULING; ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOFILM; BIOREACTOR; DISEASE TRANSMISSION; DISEASE TREATMENT; MEMBRANE; NANOTECHNOLOGY; POLYMER; RESEARCH AND DEVELOPMENT; SILVER;

ARTICLE; BACTERIAL COUNT; BIOFILM; BIOREACTOR; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; PARTICLE SIZE; PSEUDOMONAS AERUGINOSA; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY;

BIOFILMS; BIOREACTORS; COLONY COUNT, MICROBIAL; METAL NANOPARTICLES; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; POLYMERS; PSEUDOMONAS AERUGINOSA; SILVER; SPECTROPHOTOMETRY, ULTRAVIOLET; SURFACE PROPERTIES;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 84880038000     PISSN: 08927014     EISSN: 10292454     Source Type: Journal    
DOI: 10.1080/08927014.2013.794225     Document Type: Article

References (55)

1. Ahmadi, J. 2009. Application of different levels of silver nanoparticles in food on the performance and some blood parameters of broiler chickens. World Appl Sci J, 7: 24 - 27.
2. Anderl, JN, Franklin, MJ and Stewart, PS. 2000. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother, 44: 1818 - 1824.
3. Ashkarran, AA, Ghavami, M, Aghaverdi, H, Stroeve, P and Mahmoudi, M. 2012. Bacterial effects and protein corona evaluations: crucial ignored factors in the prediction of bio-efficacy of various forms of silver nanoparticles. Chem Res Toxicol, 6: 1231 - 1242.
4. ASTM International. 2007. E-2562-07: standard test method for quantification of a Pseudomonas aeruginosa biofilm grown with shear and continuous flow using a rotating disk reactor. Annual book of ASTM standards, vol. 11.05, West Conshohocken, PA: ASTM International.
5. Bakaletz, LO. 2007. Bacterial biofilms in otitis media: evidence and relevance. Pediatr Infect Dis J, 26: S17 - S19.
6. Brady, RA, Leid, JG, Calhoun, JH, Costerton, JW and Shirtliff, ME. 2008. Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol, 52: 13 - 22.
7. Buckingham-Meyer, K, Goeres, DM and Hamilton, MA. 2007. Comparative evaluation of biofilm disinfectant efficacy tests. J Microbiol Methods, 70: 236 - 244.
8. Cerca, N, Jefferson, KK, Oliveira, R, Pier, GB and Azeredo, J. 2006. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun, 78: 4849 - 4855.
9. Characklis, WG. 1990. " Laboratory biofilm reactors ". In Biofilms, Edited by: Characklis, WG and Marshall, KC. 55 - 89. New York, NY: John Wiley & Sons.
10. Chaudhry, Q, Scotter, M, Blackburn, J, Ross, B, Boxall, A and Castle, L. 2008. Applications and implications of nanotechnologies for the food sector. Food Addit Contam: Part A: Chem Anal Control Expo Risk Assess, 25: 241 - 258.
11. Costerton, JW. 2007. " Bacterial attachment to surfaces ". In The biofilm primer, Edited by: Eckey, DC. 36 - 43. Berlin: Springer.
12. Costerton, W, Veeh, R, Shirtliff, M, Pasmore, M, Post, C and Ehrlich, G. 2003. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest, 112: 1466 - 1477.
13. Donlan, RM and Costerton, JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev, 15: 167 - 193.
14. Elechiguerra, JL, Burt, JL, Morones, JR, Camacho-Bragado, A, Gao, X, Lara, HH and Yacaman, MJ. 2005. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol, 29: 3 - 6.
15. Fayaz, AM, Balaji, K, Girilal, M, Yadav, R, Kalaichelvan, PT and Venketesan, R. 2010. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against Gram-positive and Gram-negative bacteria. Nanomedicine, 6: 103 - 109.
16. Fonseca, AP and Sousa, JC. 2007. Effect of shear stress on growth, adhesion and biofilm formation of Pseudomonas aeruginosa with antibiotic-induced morphological changes. Int J Antimicrob Agents, 30: 236 - 241.
17. Goeres, DM, Loetterle, LR, Hamilton, MA, Murga, R, Kirby, DW and Donlan, RM. 2005. Statistical assessment of a laboratory method for growing biofilms. Microbiology, 151: 757 - 762.
18. Goller, CC and Romeo, T. 2008. Environmental influences on biofilm development. Curr Top Microbiol Immunol, 322: 37 - 66.
19. Gosheger, G, Hardes, J, Ahrens, H, Streitburger, A, Buerger, H, Erren, M, Gunsel, A, Kemper, FH, Winkelmann, W and Von Eiff, C. 2004. Silver-coated megaendoprostheses in a rabbit model-an analysis of the infection rate and toxicological side effects. Biomaterials, 25: 5547 - 5556.
20. Høiby, N. 2002. Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies. J Cyst Fibros, 1: 249 - 254.
21. Hong, B, Kai, J, Ren, Y, Han, J, Zou, Z and Ahn, CH. 2008. Highly sensitive rapid, reliable, and automatic cardiovascular disease diagnosis with nanoparticle fluorescence enhancer and MEMS. Adv Exp Med Biol, 614: 265 - 273.
22. Imamura, Y, Chandra, J, Mukherjee, PK, Lattif, AA, Szczotka-Flynn, LB, Pearlman, E, Lass, JH, O'Donnell, K and Ghannoum, MA. 2008. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother, 52: 171 - 182.
23. Jacobsen, SM, Stickler, DJ, Mobley, HL and Shirtliff, ME. 2008. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev, 21: 26 - 59.
24. James, GA, Swogger, E, Wolcott, R, Pulcini, E, Secor, P, Sestrich, J, Costerton, JW and Stewart, PS. 2008. Biofilms in chronic wounds. Wound Repair Regen, 16: 37 - 44.
25. Kalishwaralal, K, BarathManiKanth, S, Pandian, SR, Deepak, V and Gurunathan, S. 2010. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf, B, 79: 340 - 344.
26. Kim, JS, Kuk, E, Yu, KN, Kim, JH, Park, SJ, Lee, HJ, Kim, SH, Park, YK, Park, YH Hwang, CY. 2007. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med, 3: 95 - 101.
27. Kim, S, Choi, JE, Choi, J, Chung, KH, Park, K, Yi, J and Ryu, DY. 2009. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro, 23: 1076 - 1084.
28. Liu, Y, Wang, L, Zhou, X, Hu, S, Zhang, S and Wu, H. 2011. Effect of the antimicrobial decapeptide KSL on the growth of oral pathogens and Streptococcus mutans biofilm. Int J Antimicrob Agents, 37: 33 - 38.
29. Lynch, AS and Robertson, GT. 2008. Bacterial and fungal biofilm infections. Ann Rev Med, 59: 415 - 428.
30. Maha, TF and O'Toole, GA. 2001. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol, 9: 34 - 39.
31. Mahmoudi, M and Serpooshan, V. 2012. Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat. ACS Nano, 6: 2656 - 2664.
32. Maki, DG. 2010. In vitro studies of a novel antimicrobial luer-activated needleless connector for prevention of catheter-related bloodstream infection. Clin Infect Dis, 50: 1580 - 1587.
33. Martínez-Gutierrez, F, Olive, PL, Banuelos, A, Orrantia, E, Nino, N, Sanchez, EM, Ruiz, F, Bach, H and Av-Gay, Y. 2010. Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles. Nanomed Nanotechnol Biol Med, 6: 681 - 688.
34. Martínez-Gutierrez, F, Thi, EP, Silverman, JM, de Oliveira, CC, Svensson, SL, Vanden Hoek, A, Sánchez, EM, Reiner, NE, Gaynor, EC Pryzdial, EL. 2012. Antibacterial activity, inflammatory response, coagulation and cytotoxicity effects of silver nanoparticles. Nanomed Nanotechnol Biol Med, 8: 328 - 336.
35. Matsukawa, M and Greenberg, EP. 2004. Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm development. J Bacteriol, 86: 4449 - 4456.
36. Paddle-Ledinek, JE, Nasa, Z and Cleland, HJ. 2006. Effect of different wound dressings on cell viability and proliferation. Plast Reconstr Surg, 117: 110S - 118S.
37. Park, MV, Neigh, AM, Vermeulen, JP, de la Fonteyne, LJ, Verharen, HW, Briedé, JJ, van Loveren, H and de Jong, WH. 2011. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials, 32: 9810 - 9817.
38. Post, JC, Hiller, NL, Nistico, L, Stoodley, P and Ehrlich, GD. 2007. The role of biofilms in otolaryngologic infections. Curr Opin Otolaryngol Head Neck Surg, 15: 347 - 351.
39. Prabhakara, PK, Raja, S, Anuradhab, PR, Sawantb, SN and Doblea, M. 2011. Biocompatibility studies on polyaniline and polyaniline-silver nanoparticle coated polyurethane composite. Colloids Surf, B, 86: 146 - 153.
40. Sawada, I, Fachrul, R, Ito, T, Ohmukai, Y, Maruyama, T and Matsuyama, H. 2012. Development of a hydrophilic polymer membrane containing silver nanoparticles with both organic antifouling and antibacterial properties. J Membr Sci, 387-388: 1 - 6.
41. Seil, JT and Webster, TJ. 2011. Reduced Staphylococcus aureus proliferation and biofilm formation on zinc oxide nanoparticle PVC composite surfaces. Acta Biomater, 7: 2579 - 2584.
42. Stewart, PS. 2003. Diffusion in biofilms. J Bacteriol, 185: 1485 - 1491.
43. Stewart, PS and Costerton, JW. 2001. Antibiotic resistance of bacteria in biofilms. Lancet, 358: 135 - 138.
44. Stewart, PS and Franklin, MJ. 2008. Physiological heterogeneity in biofilms. Nat Rev Microbiol, 6: 199 - 210.
45. Stoodley, P, DeBeer, D and Lewandowski, Z. 1994. Liquid flow in biofilm systems. Appl Environ Microbiol, 60: 2711 - 2716.
46. Subbiahdoss, G, Sharifi, S, Grijpma, DW, Laurent, S, Van der Mei, HC, Mahmoudi, M and Busscher, HJ. 2012. Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphlococci. Acta Biomater, 8: 2047 - 2055.
47. Sutherland, IW. 2001. The biofilm matrix-an immobilized but dynamic microbial environment. Trends Microbiol, 9: 222 - 227.
48. Teodosio, JS, Simoes, M, Melo, LF and Mergulhao, FJ. 2011. Flow cell hydrodynamics and their effects on E. coli biofilm formation under different nutrient conditions and turbulent flow. Biofouling, 27: 1 - 11.
49. Ulkur, E, Oncul, O, Karagoz, H, Yeniz, E and Celikoz, B. 2005. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bacti-grass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant staphylococcoi-contaminated, full-skin thickness rat burn wounds. Burns, 31: 874 - 877.
50. Vieira, MJ, Melo, LF and Phinheiro, MM. 1993. Biofilm formation: hydrodynamic effects on internal diffusion and structure. Biofouling, 7: 67 - 80.
51. Walters, MC III, Roe, F, Bugnicourt, A, Franklin, MJ and Stewart, PS. 2003. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother, 47: 317 - 323.
52. Wasche, S, Horn, H and Hempel, DC. 2000. Mass transfer phenomena in biofilm systems. Water Sci Technol, 41: 357 - 360.
53. Zelver, N, Hamilton, M, Goeres, D and Heersink, J. 2001. Development of a standardized antibiofilm test. Methods Enzymol, 337: 363 - 376.
54. Zhang, L, Gu, FX, Chan, JM, Wang, AZ, Langer, RS and Farokhzad, OC. 2008. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther, 83: 761 - 769.
55. Zodrow, K, Brunet, L, Mahendra, S, Li, D, Zhang, A, Li, Q and Alvarez, PJJ. 2009. Polysulfone ultrafiltration membranes impregnated with silver nanoparticles show improved biofouling resistance and virus removal. Water Res, 43: 715 - 723.